Awareness and Willingness to Use HIV Infection Pre-Exposure Prophylaxis among Rwandan Men Who Have Sex with Men: Findings from a Web-based Survey

Author:

Munyaneza AthanaseORCID,Patel Viraj V.ORCID,Gutierrez Nataly Rios,Shi QiuhuORCID,Muhoza Benjamin,Kubwimana Gallican,Ross JonathanORCID,Nsereko EtienneORCID,Murenzi Gad,Nyirazinyoye Laetitia,Mutesa Leon,Anastos Kathryn,Adedimeji Adebola

Abstract

AbstractIntroductionPre-exposure Prophylaxis (PrEP) is a daily pill intended to reduce the risk of acquiring Human Immunodeficiency Virus (HIV) when taken as prescribed. It is strongly recommended for Men who have sex with Men (MSM) at high risk of HIV transmission to minimize infection risk. Despite its proven effectiveness, there is a lack of information about awareness and willingness to use PrEP among Rwandan MSM. In the context of HIV acquisition, the purpose of this study was to ascertain the awareness and willingness to use PrEP among high-risk Rwandan MSM. The findings of this research will provide valuable perspectives to mold policy and direct the effective execution of PrEP within the country.MethodThis is a cross-sectional study design that utilized a web-based survey conducted between April and June 2019 to assess awareness and willingness to use PrEP among sexually active MSM in Rwanda. A snowball sampling technique was used to recruit participants who were contacted via social medial such as WhatsApp and e-mail. To be eligible, participants were supposed to be sexually active, aged ≥18 years, self-identify as MSM, residence in Rwanda, self-reported engagement in receptive or insertive anal sex in the last 12 months, and self-reported HIV-negative sero-status. We assessed two primary outcomes: PrEP awareness (having ever heard of PrEP) and willingness to use PrEP within one month of completing the survey. Multivariable logistic regression was performed to identify participant characteristics associated with PrEP awareness and willingness to use it.ResultsAmong the 521 participants included in the analysis, 63% were aged below 24 years. The majority (73%) demonstrated awareness of PrEP. Factors associated with PrEP awareness included residing outside of the capital, Kigali, as opposed to living in Kigali (adjusted odds ratio [aOR] 2.35, 95% confidence interval [CI] 1.40-3.97), being in the age groups 18-24 years (aOR 2.28, 95% CI: 1.03-5.01) or 25-29 years (aOR 3.06, 95% CI 1.35-6.93) compared to those aged 30 or older, having higher education levels, such as completing secondary education (aOR 1.76, 95% CI 1.01-3.06) or university education (aOR 2.65, 95% CI 1.18-5.96) in contrast to having no education. Lastly, perceiving a benefit from PrEP (aOR 9.52, 95% CI 4.27-21.22), and engaging in vaginal sex with a woman using a condom in the last 12 months (aOR 1.82, 95% CI 1.14-2.91) versus not. Impressively, 96% of participants expressed a strong willingness to use PrEP.ConclusionAmong Rwandan MSM, there is a high level of awareness of PrEP, notably associated with factors such as residing outside Kigali, younger age, higher education, perceived benefits of PrEP and condom use during vaginal sex in the past year. Furthermore, a significant portion of participants demonstrated an intense desire to use PrEP, suggesting promising possibilities for its extensive implementation among this group of people. The findings from this study emphasize the importance of implementing highly focused awareness campaigns, personalized intervention, and comprehensive sexual health education programs in order to enhance the adoption of PrEP and bolster HIV prevention initiatives among the Rwandan population of MSM

Publisher

Cold Spring Harbor Laboratory

Reference44 articles.

1. Centers for Disease Control and Prevention. New HIV Diagnoses in the US and Dependent Areas for the Most-Affected Subpopulations, 2020. HIV Surveillance Report. [Internet]. 2022. Available from: https://www.cdc.gov/hiv/images/statistics/overview/in-us/infographics/cdc-hiv-most-affected-infographic-1920x1008.png

2. WHO. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: What’s New [Internet]. World Health Organization. Geneva, Switzerland, 2016 [cited 2022 May 19]. Available from: https://apps.who.int/iris/bitstream/handle/10665/208825/97892?sequence=1

3. UNAIDS. HIV Prevention 2020 Road Map: Accelerating HIV prevention to reduce new infections by 75%. [Internet]. 20 Avenue Appia 1211 Geneva 27 Switzerland, 2020. Available from: https://www.unaids.org/sites/default/files/media_asset/hiv-prevention-2020-road-map_en.pdf

4. UNAIDS. New HIV and other men who have sex with men increasing [Internet]. 2020. Available from: https://www.unaids.org/en/resources/presscentre/featurestories/2020/december/20201207_new-hiv-infections-increasing#:~:text=people who injec-, In 2019%2C key populations (including gay men and other men,other than eastern and southern

5. RBC. National HIV and Viral Hepatatis Annual Report 2020-2021 [Internet]. Kigali, 2021. Available from: https://www.globalhep.org/sites/default/files/content/resource/files/2021-09/Annual Report for HIV and Viral Hepatitis 2020-2021.pdf

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3